Leilani Morales
About
In The Last Decade
Leilani Morales
10 papers receiving 373 citations
Peers
Comparison fields: 5 of 57
- Genetics 246
- Oncology 222
- Endocrinology, Diabetes and Metabolism 94
- Cancer Research 68
- Pulmonary and Respiratory Medicine 41
Countries citing papers authored by Leilani Morales
This map shows the geographic impact of Leilani Morales's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leilani Morales with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leilani Morales more than expected).
Fields of papers citing papers by Leilani Morales
This network shows the impact of papers produced by Leilani Morales. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leilani Morales. The network helps show where Leilani Morales may publish in the future.
Co-authorship network of co-authors of Leilani Morales
This figure shows the co-authorship network connecting the top 25 collaborators of Leilani Morales. A scholar is included among the top collaborators of Leilani Morales based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leilani Morales. Leilani Morales is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 5 | |
| 3 | 115 | |
| 4 | 8 | |
| 5 | 95 | |
| 6 | 15 | |
| 7 | 26 | |
| 8 | 118 | |
| 9 | Prospective study on the effect of endocrine treatments on menopausal symptoms in breast cancer patients | 1 |
| 10 | Prospective study of uterine sonographic changes after 3 months endocrine treatment in postmenopausal breast cancer patients: tamoxifen is estrogenic while aromatase inhibitors induce atrophy and can reverse the effect of tamoxifen | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.